MARCHEX INC-CLASS B (MCHX) Fundamental Analysis & Valuation

NASDAQ:MCHX • US56624R1086

Current stock price

1.43 USD
-0.08 (-5.3%)
Last:

This MCHX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MCHX Profitability Analysis

1.1 Basic Checks

  • MCHX had negative earnings in the past year.
  • In the past year MCHX has reported a negative cash flow from operations.
  • In the past 5 years MCHX always reported negative net income.
  • In the past 5 years MCHX always reported negative operating cash flow.
MCHX Yearly Net Income VS EBIT VS OCF VS FCFMCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • MCHX has a Return On Assets of -11.73%. This is in the lower half of the industry: MCHX underperforms 63.04% of its industry peers.
  • MCHX's Return On Equity of -15.11% is in line compared to the rest of the industry. MCHX outperforms 51.09% of its industry peers.
Industry RankSector Rank
ROA -11.73%
ROE -15.11%
ROIC N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
MCHX Yearly ROA, ROE, ROICMCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • The Gross Margin of MCHX (63.68%) is better than 79.35% of its industry peers.
  • In the last couple of years the Gross Margin of MCHX has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for MCHX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
MCHX Yearly Profit, Operating, Gross MarginsMCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. MCHX Health Analysis

2.1 Basic Checks

  • MCHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MCHX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MCHX has been reduced compared to 5 years ago.
  • MCHX has a better debt/assets ratio than last year.
MCHX Yearly Shares OutstandingMCHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MCHX Yearly Total Debt VS Total AssetsMCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • MCHX has an Altman-Z score of -5.78. This is a bad value and indicates that MCHX is not financially healthy and even has some risk of bankruptcy.
  • MCHX's Altman-Z score of -5.78 is on the low side compared to the rest of the industry. MCHX is outperformed by 83.70% of its industry peers.
  • MCHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.78
ROIC/WACCN/A
WACC8.98%
MCHX Yearly LT Debt VS Equity VS FCFMCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 2.53 indicates that MCHX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.53, MCHX belongs to the best of the industry, outperforming 84.78% of the companies in the same industry.
  • MCHX has a Quick Ratio of 2.53. This indicates that MCHX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.53, MCHX belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 2.53
MCHX Yearly Current Assets VS Current LiabilitesMCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MCHX Growth Analysis

3.1 Past

  • The earnings per share for MCHX have decreased by 0.00% in the last year.
  • The Revenue has decreased by -4.32% in the past year.
  • Measured over the past years, MCHX shows a decrease in Revenue. The Revenue has been decreasing by -2.46% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-8.28%

3.2 Future

  • Based on estimates for the next years, MCHX will show a very strong growth in Earnings Per Share. The EPS will grow by 45.86% on average per year.
  • Based on estimates for the next years, MCHX will show a small growth in Revenue. The Revenue will grow by 0.39% on average per year.
EPS Next Y61.75%
EPS Next 2Y45.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.54%
Revenue Next 2Y0.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHX Yearly Revenue VS EstimatesMCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MCHX Yearly EPS VS EstimatesMCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. MCHX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MCHX. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 140.20, the valuation of MCHX can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MCHX.
  • When comparing the Price/Forward Earnings ratio of MCHX to the average of the S&P500 Index (23.72), we can say MCHX is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 140.2
MCHX Price Earnings VS Forward Price EarningsMCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCHX Per share dataMCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MCHX's earnings are expected to grow with 45.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.86%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MCHX Dividend Analysis

5.1 Amount

  • No dividends for MCHX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MCHX Fundamentals: All Metrics, Ratios and Statistics

MARCHEX INC-CLASS B

NASDAQ:MCHX (3/19/2026, 8:13:50 PM)

1.43

-0.08 (-5.3%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners64.01%
Inst Owner Change-0.3%
Ins Owners8.34%
Ins Owner Change0%
Market Cap62.79M
Revenue(TTM)46.49M
Net Income(TTM)-4.83M
Analysts82.86
Price Target4.08 (185.31%)
Short Float %0.07%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)98.04%
Min EPS beat(2)-100%
Max EPS beat(2)296.08%
EPS beat(4)1
Avg EPS beat(4)13.24%
Min EPS beat(4)-100%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)3.51%
EPS beat(12)5
Avg EPS beat(12)-3.44%
EPS beat(16)9
Avg EPS beat(16)8%
Revenue beat(2)0
Avg Revenue beat(2)-6.5%
Min Revenue beat(2)-7.85%
Max Revenue beat(2)-5.14%
Revenue beat(4)0
Avg Revenue beat(4)-5.47%
Min Revenue beat(4)-7.85%
Max Revenue beat(4)-2.69%
Revenue beat(8)0
Avg Revenue beat(8)-4.54%
Revenue beat(12)0
Avg Revenue beat(12)-4.05%
Revenue beat(16)1
Avg Revenue beat(16)-3.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 140.2
P/S 1.35
P/FCF N/A
P/OCF N/A
P/B 1.97
P/tB 4.37
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.01
Fwd EY0.71%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS1.06
BVpS0.73
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.73%
ROE -15.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.68%
FCFM N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.09%
Cap/Sales 2.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.53
Quick Ratio 2.53
Altman-Z -5.78
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)40.99%
Cap/Depr(5y)32.87%
Cap/Sales(3y)3.05%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y61.75%
EPS Next 2Y45.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-8.28%
Revenue Next Year-5.54%
Revenue Next 2Y0.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year119.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.17%
OCF growth 3YN/A
OCF growth 5YN/A

MARCHEX INC-CLASS B / MCHX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MARCHEX INC-CLASS B?

ChartMill assigns a fundamental rating of 3 / 10 to MCHX.


Can you provide the valuation status for MARCHEX INC-CLASS B?

ChartMill assigns a valuation rating of 1 / 10 to MARCHEX INC-CLASS B (MCHX). This can be considered as Overvalued.


Can you provide the profitability details for MARCHEX INC-CLASS B?

MARCHEX INC-CLASS B (MCHX) has a profitability rating of 1 / 10.


What is the financial health of MARCHEX INC-CLASS B (MCHX) stock?

The financial health rating of MARCHEX INC-CLASS B (MCHX) is 7 / 10.


Can you provide the dividend sustainability for MCHX stock?

The dividend rating of MARCHEX INC-CLASS B (MCHX) is 0 / 10 and the dividend payout ratio is 0%.